Summary:
- This article discusses Treeline Bio's first clinical programs, which are focused on developing new medicines.
- The article explains that Treeline Bio is working on two drug candidates that are currently in early-stage clinical trials.
- One of the drug candidates is designed to treat a rare genetic disorder, while the other is being developed to address a common neurological condition.